Jenny Sprooten

1.6k total citations
12 papers, 649 citations indexed

About

Jenny Sprooten is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Jenny Sprooten has authored 12 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Jenny Sprooten's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (8 papers) and vaccines and immunoinformatics approaches (3 papers). Jenny Sprooten is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (8 papers) and vaccines and immunoinformatics approaches (3 papers). Jenny Sprooten collaborates with scholars based in Belgium, United States and France. Jenny Sprooten's co-authors include Abhishek D. Garg, Patrizia Agostinis, Isaure Vanmeerbeek, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer, Sabine Tejpar, Dirk De Ruysscher, Jitka Fučíková and Peter Vandenberghe and has published in prestigious journals such as Science Advances, Immunological Reviews and Cells.

In The Last Decade

Jenny Sprooten

12 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jenny Sprooten Belgium	10	381	317	248	112	88	12	649
Aitian Li China	7	259 0.7×	328 1.0×	265 1.1×	80 0.7×	98 1.1×	11	665
Hualing Zhang China	5	343 0.9×	360 1.1×	254 1.0×	137 1.2×	125 1.4×	8	708
Qianqian Duan China	7	340 0.9×	378 1.2×	293 1.2×	169 1.5×	138 1.6×	31	792
Ling Lin China	10	398 1.0×	333 1.1×	366 1.5×	73 0.7×	197 2.2×	12	819
Elena García-Martínez Spain	9	365 1.0×	284 0.9×	246 1.0×	61 0.5×	135 1.5×	12	682
Tomáš Brtnický Czechia	8	485 1.3×	364 1.1×	145 0.6×	57 0.5×	49 0.6×	13	688
Ann‐Charlotte Björklund Sweden	7	438 1.1×	252 0.8×	268 1.1×	61 0.5×	51 0.6×	12	791
William R. Gwin United States	13	295 0.8×	426 1.3×	272 1.1×	82 0.7×	52 0.6×	34	669
Changzheng Lu United States	11	292 0.8×	221 0.7×	252 1.0×	67 0.6×	104 1.2×	14	564
Nam-Chul Jung South Korea	13	336 0.9×	195 0.6×	209 0.8×	55 0.5×	37 0.4×	18	609

Countries citing papers authored by Jenny Sprooten

Since Specialization

Citations

This map shows the geographic impact of Jenny Sprooten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Sprooten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Sprooten more than expected).

Fields of papers citing papers by Jenny Sprooten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Sprooten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Sprooten. The network helps show where Jenny Sprooten may publish in the future.

Co-authorship network of co-authors of Jenny Sprooten

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Sprooten. A scholar is included among the top collaborators of Jenny Sprooten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Sprooten. Jenny Sprooten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Vanmeerbeek, Isaure, Stefan Naulaerts, Jenny Sprooten, et al.. (2024). Targeting conserved TIM3 ⁺ VISTA ⁺ tumor-associated macrophages overcomes resistance to cancer immunotherapy. Science Advances. 10(29). eadm8660–eadm8660. 22 indexed citations

Sprooten, Jenny & Abhishek D. Garg. (2024). Next-generation DC vaccines with an immunogenic trajectory against cancer: therapeutic opportunities vs. resistance mechanisms. Genes and Immunity. 26(2). 166–168. 2 indexed citations

Laureano, Raquel S., Isaure Vanmeerbeek, Jenny Sprooten, et al.. (2024). Trial watch: anticancer vaccination with dendritic cells. OncoImmunology. 13(1). 2412876–2412876. 15 indexed citations

Laureano, Raquel S., Isaure Vanmeerbeek, Jenny Sprooten, et al.. (2023). The cell stress and immunity cycle in cancer: Toward next generation of cancer immunotherapy. Immunological Reviews. 321(1). 71–93. 7 indexed citations

Vanmeerbeek, Isaure, Jannes Govaerts, Raquel S. Laureano, et al.. (2022). The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology. Cells. 11(23). 3890–3890. 15 indexed citations

Vanmeerbeek, Isaure, Daniel Borràs, Jenny Sprooten, et al.. (2021). Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy. Genes and Immunity. 22(2). 108–119. 12 indexed citations

Vaes, Rianne D.W., Kobe Reynders, Jenny Sprooten, et al.. (2021). Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study. Cancers. 13(24). 6259–6259. 20 indexed citations

Sprooten, Jenny, Isaure Vanmeerbeek, Shaun Martin, et al.. (2020). Necroptosis in Immuno-Oncology and Cancer Immunotherapy. Cells. 9(8). 1823–1823. 123 indexed citations

Vanmeerbeek, Isaure, Jenny Sprooten, Dirk De Ruysscher, et al.. (2020). Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology. 9(1). 1703449–1703449. 181 indexed citations

10.

Sprooten, Jenny, Patrizia Agostinis, & Abhishek D. Garg. (2019). Type I interferons and dendritic cells in cancer immunotherapy. International review of cell and molecular biology. 348. 217–262. 93 indexed citations

11.

Sprooten, Jenny, Jolien Ceusters, An Coosemans, et al.. (2019). Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology. 8(11). 1638212–1638212. 115 indexed citations

12.

Sprooten, Jenny & Abhishek D. Garg. (2019). Type I interferons and endoplasmic reticulum stress in health and disease. International review of cell and molecular biology. 63–118. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact